about
Nucleic Acid sensors and type I interferon production in systemic lupus erythematosusThe role of genetic variation near interferon-kappa in systemic lupus erythematosusRheumatologic manifestations of sarcoidosisNetwork analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosusGenetic regulation of serum cytokines in systemic lupus erythematosusGenetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patientsThe unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies.Interferon alpha in systemic lupus erythematosusPromoter variant of PIK3C3 is associated with autoimmunity against Ro and Sm epitopes in African-American lupus patients.Linkage of type I interferon activity and TNF-alpha levels in serum with sarcoidosis manifestations and ancestryTrait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus.Interferon regulatory factors in human lupus pathogenesisGenetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus.Dual B cell immunotherapy is superior to individual anti-CD20 depletion or BAFF blockade in murine models of spontaneous or accelerated lupus.Interferon alpha as a primary pathogenic factor in human lupusCytokine disturbances in systemic lupus erythematosus.Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-α and serologic autoimmunity in lupus patients.Gene-expression-guided selection of candidate loci and molecular phenotype analyses enhance genetic discovery in systemic lupus erythematosus.The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases.Activation of the Interferon Pathway is Dependent Upon Autoantibodies in African-American SLE Patients, but Not in European-American SLE Patients.Familial aggregation of high tumor necrosis factor alpha levels in systemic lupus erythematosus.Genetic variation near IRF8 is associated with serologic and cytokine profiles in systemic lupus erythematosus and multiple sclerosis.Genetics of the type I interferon pathway in systemic lupus erythematosus.Clinically validated approaches to the treatment of autoimmune diseases.Type I interferon therapy and its role in autoimmunity.Interferon regulatory factor 5 in the pathogenesis of systemic lupus erythematosus.Induction of Systemic Autoimmunity by a Xenobiotic Requires Endosomal TLR Trafficking and Signaling from the Late Endosome and Endolysosome but Not Type I IFN.NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus.Increased RNA Editing May Provide a Source for Autoantigens in Systemic Lupus Erythematosus.Report of the inaugural Interferon Research Summit: interferon in inflammatory diseases.Defining biological subsets in systemic lupus erythematosus: progress toward personalized therapy.Identification of a gene-expression predictor for diagnosis and personalized stratification of lupus patients.
P2860
Q21131202-F917B1C8-9EA0-48DB-9277-C8673B1FC80FQ21296846-D5143295-8826-48FC-8257-71F07F48EFB8Q24608644-976FA134-6ED8-418F-8C26-480221F2B28CQ28301151-3AFC1657-BE90-4D5C-AB63-19C98ED1A1D6Q33682879-FD2EBDA0-32B8-4D8D-9478-05B011D375B1Q33703923-E97A50BF-E903-4613-AAB2-E62839D0AACAQ33939981-08BB889B-7C73-44EB-912A-26965112382BQ33961179-BB753C8D-A11B-4C12-A8B4-2C221AE59F8AQ34022033-6BE21C26-3A4C-45A1-A713-AE45D0222D04Q34110737-FA5C59FA-0723-452C-BE6B-D2142D10286BQ34153062-60576122-52C8-44D9-BBD9-F9525883142AQ34988497-6E1F11BE-F571-4B99-9D6F-34C360B7AC6FQ35008001-E2202FAF-5E1C-4D85-816D-84C7F9360EBEQ35035048-EE1F7999-AFBD-47EE-8C51-2C683C4F80E3Q35603587-15DE3F4F-87F9-4BC5-A718-8220E4314459Q35617573-16AC3C52-B372-4FEE-BAD4-268398C297EEQ35832527-41913105-2CF1-4085-BAEF-237CDA84ABBBQ36228760-3C434867-F69D-4EE8-B956-D7FC8687DDB8Q36338717-387FCADC-67C6-47CE-A731-480262655B9AQ37208233-55DD40AD-0191-4369-AC44-1BC88AAC8A04Q37239812-9391D4E5-F76A-469D-8605-A24E253EEF24Q37375806-A021C08F-78D1-4932-B22C-8424B3830DC2Q37450879-F43A0C19-80C9-405A-AC75-F40BC81A662CQ37668612-B77C5807-0524-41AB-877D-29F2FEE826BDQ37713730-B33C1076-143D-4715-82F2-B2FD10D440ABQ38068405-1DFC5C4E-E09B-44D9-AC6D-99168813913BQ47621572-2D7D05E8-6F9E-4F14-871E-01DB4039F4AEQ48250996-7D801B19-7475-4A3E-953F-FEE0D9CB3A1BQ52607307-90046101-3D99-448F-BB37-E96CC90C6528Q55383884-ACD977C8-8708-4A40-B4D9-7A0143CF1627Q55409997-D44E1B13-EE56-4962-BF6E-361456D67761Q55716933-2B7CBEA9-8B05-455F-8754-CE73F20B2E22
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Interferon alpha-induced lupus: proof of principle
@ast
Interferon alpha-induced lupus: proof of principle
@en
Interferon alpha-induced lupus: proof of principle
@nl
type
label
Interferon alpha-induced lupus: proof of principle
@ast
Interferon alpha-induced lupus: proof of principle
@en
Interferon alpha-induced lupus: proof of principle
@nl
prefLabel
Interferon alpha-induced lupus: proof of principle
@ast
Interferon alpha-induced lupus: proof of principle
@en
Interferon alpha-induced lupus: proof of principle
@nl
P2860
P1476
Interferon alpha-induced lupus: proof of principle
@en
P2860
P356
10.1097/RHU.0B013E318177627D
P407
P577
2008-06-01T00:00:00Z